Duality Advisers’s Eli Lilly LLY Stock Holding History

Duality Advisers’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,869	Closed	-$6.12M	–	307
2024 Q1	$6.12M	Sell	7,869 -2,905	-27%	-$2.07M	0.6%	18
2023 Q4	$6.28M	Buy	10,774 +2,253	+26%	+$1.32M	0.66%	10
2023 Q3	$4.58M	Buy	+8,521	New	+$4.39M	0.55%	25
2022 Q2	–	Sell	-1,741	Closed	-$499K	–	744
2022 Q1	$499K	Buy	+1,741	New	+$448K	0.05%	472
2021 Q4	–	Sell	-16,496	Closed	-$3.81M	–	608
2021 Q3	$3.81M	Buy	+16,496	New	+$4.07M	0.29%	132
2021 Q2	–	Sell	-46,594	Closed	-$8.71M	–	648
2021 Q1	$8.71M	Buy	+46,594	New	+$9.11M	0.76%	2
2020 Q4	–	Sell	-9,110	Closed	-$1.35M	–	648
2020 Q3	$1.35M	Buy	+9,110	New	+$1.41M	0.09%	301
2019 Q4	–	Sell	-3,870	Closed	-$433K	–	410
2019 Q3	$433K	Sell	3,870 -110,380	-97%	-$12.3M	0.02%	303
2019 Q2	$12.7M	Buy	+114,250	New	+$13.5M	1.11%	16

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Duality Advisers's LLY Position: Q2 2024 in Review

Duality Advisers sold out of Eli Lilly (LLY) in Q2 2024, closing a stake of 7,869 shares — an estimated $6.12M sold.

Duality Advisers first reported a position in LLY in Q2 2019 and held it in 9 quarters. The position peaked at $12.7M in Q2 2019. 3,564 funds tracked by Wall St. Rank hold LLY as of Q2 2024.

Duality Advisers reported no remaining Eli Lilly position as of Q2 2024 after selling out during the quarter.
Duality Advisers sold 7,869 Eli Lilly shares in Q2 2024, an estimated $6.12M.
Duality Advisers first reported a position in Eli Lilly in Q2 2019 and held it in 9 quarters.
Duality Advisers's Eli Lilly position peaked at $12.7M in Q2 2019.
3,564 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.

Based on Duality Advisers's 13F filing for Q2 2024.